Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Biopharma Confronts a Rising Tide of Ransomware Attacks
BioSpace
Wed, 06/14/23 - 10:11 am
Tags:
cyberattacks
,
cybersecurity
,
ransomware
,
Eisai
,
Sun Pharma
,
Novartis
,
AstraZeneca
,
Merck
Merck Gets FDA Fast Track for Efinopegdutide, Previews NASH Data Versus Novo’s Semaglutide
BioSpace
Wed, 06/14/23 - 10:08 am
Tags:
Merck
,
efinopegdutide
,
FDA
,
NASH
,
fast track
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Tue, 06/13/23 - 10:49 pm
Tags:
Merck
,
Keytruda
,
Bristol Myers Squibb
,
Ono
,
patents
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis
,
Chinook Therapeutics
,
Paratek
,
Sobi
,
CTI BioPharma
,
Astellas
,
Iveric Bio
,
Assertio Holdings
,
Spectrum Pharmaceuticals
,
Merck
,
Prometheus Biosciences
,
Pfizer
,
Seagen
,
Sanofi
,
Provention Bio
,
Sun Pharma
,
Concert Pharmaceuticals
,
BioNTech
,
InstaDeep
,
AstraXeneca
,
CinCor Pharma
,
Ipsen
,
Albireo
,
Chiesi
,
Amryt
,
Moderna Therapeutics
,
OriCiro Genomics
Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider
Fierce Pharma
Fri, 06/9/23 - 11:49 am
Tags:
Merck
,
Inflation Reduction Act
,
legal
,
shareholders
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
Fri, 06/9/23 - 10:15 am
Tags:
AstraZeneca
,
Merck
,
Lynparza
,
NICE
,
UK
,
ovarian cancer
,
fallopian tube cancer
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
Tags:
ASCO 2023
,
oncologists
,
cancer
,
AstraZeneca
,
Tagrisso
,
non-small cell lung cancer
,
Novartis
,
Kisqali
,
breast cancer
,
Merck
,
Keytruda
,
Moderna Therapeutics
,
cancer vaccine
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Tags:
Merck
,
Inflation Reduction Act
,
legal
,
drug pricing
,
Biogen
,
Novartis
,
Genentech
,
BIO 2023
ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer
Fierce Pharma
Tue, 06/6/23 - 04:19 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
EGFR lung cancer
,
Roche
,
Tecentriq
,
kidney cancer
FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
Healio
Tue, 06/6/23 - 04:15 pm
Tags:
Merck
,
FDA
,
letermovir
,
CMV
,
kidney transplants
,
Prevymis
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Yahoo/Reuters
Tue, 06/6/23 - 10:04 am
Tags:
ASCO 2023
,
Merck
,
Moderna Therapeutics
,
MRNA
,
vaccines
,
skin cancer
Merck sues US government to halt Medicare drug price negotiation
Reuters
Tue, 06/6/23 - 09:59 am
Tags:
Merck
,
legal
,
Inflation Reduction Act
,
drug pricing
,
Medicare
ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm
Fierce Pharma
Sun, 06/4/23 - 04:22 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
non-small cell lung cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:49 am
Tags:
AstraZeneca
,
Merck
,
Lynparza
,
prostate cancer
,
FDA
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
Wed, 05/31/23 - 11:10 am
Tags:
vaccines
,
MRNA
,
Merck
,
Asia-Pacific
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
Merck and Eisai tease results for renal carcinoma treatment
Clinical Trials Arena
Tue, 05/30/23 - 09:18 pm
Tags:
Merck
,
Eisai
,
ASCO 2023
,
Lenvima
,
Keytruda
,
renal cell carcinoma
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
BioPharma Dive
Thu, 05/25/23 - 08:51 pm
Tags:
ASCO 2023
,
antibody-drug conjugate
,
Merck
,
BioNTech
,
Daiichi Sankyo
ASCO: Merck gives final look at Keytruda study in first-line cervical cancer. Will FDA change its mind?
Fierce Pharma
Thu, 05/25/23 - 08:37 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
cervical cancer
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
Novartis
,
Kisqali
,
non-small cell lung cancer
,
early breast cancer
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.